Telesis Bio Reports Second Quarter 2023 Financial Results
10 août 2023 16h05 HE
|
Telesis Bio
SAN DIEGO, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today reported financial results for the second...
Telesis Bio to Report Second Quarter Financial Results on Thursday, August 10, 2023
03 août 2023 17h00 HE
|
Telesis Bio
SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Telesis Bio (Nasdaq: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced that it will release its second quarter...
Telesis Bio to Present at Jefferies Healthcare Conference 2023
08 juin 2023 09h05 HE
|
Telesis Bio
SAN DIEGO, June 08, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, announced that Todd R. Nelson, Ph.D., CEO and Founder...
Telesis Bio to Present at Antibody Engineering and Therapeutics, Europe 2023
06 juin 2023 03h00 HE
|
Telesis Bio
SAN DIEGO, June 06, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their...
Telesis Bio Announces Closing of $28.0 Million Private Placement of Preferred Stock And Warrants to Purchase an Additional $46.2 Million of Common Stock
05 juin 2023 17h30 HE
|
Telesis Bio
SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in molecular biology automation solutions for multi-omic and synthetic biology applications, today announced...
Telesis Bio Secures Financing of $28.0 Million
31 mai 2023 17h29 HE
|
Telesis Bio
Up to an Additional $46.2 Million Available Through Warrant Exercise Led by Novalis LifeSciences LLC with participation from Northpond Ventures, M-185 Corporation and BroadOak Capital Partners SAN...
Telesis Bio to Present at SynBioBeta 2023
23 mai 2023 09h00 HE
|
Telesis Bio
SAN DIEGO, May 23, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop...
Telesis Bio Announces First Commercial Shipment of BioXp® Select DNA Cloning Kit
22 mai 2023 12h00 HE
|
Telesis Bio
SAN DIEGO, May 22, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
Telesis Bio Announces First Commercial Shipment of BioXp® NGS Library Prep Kit
18 mai 2023 10h00 HE
|
Telesis Bio
SAN DIEGO, May 18, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced the first commercial shipment of its...
Telesis Bio to Present at Protein Engineering Summit (PEGS Boston 2023)
15 mai 2023 09h00 HE
|
Telesis Bio
SAN DIEGO, May 15, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced they will be showcasing their benchtop...